An increasing number of studies suggest the involvement of aberrant MTA2 expression in tumor proliferation, metastasis, and chemotherapeutic agent resistance and indicate that MTA2 expression levels correlate with tumor characteristics such as size, grade, and lymph node metastasis in a variety of cancers [24, 25]. This evidence concerns the gene MTA2 and neoplasm.